CD47 is up-regulated on leukaemia cells to avoid apoptosis in vitro

2Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Treatment failure in T-cell acute lymphoblastic leukaemia (T-ALL) occurs when leukemic blasts acquire resistance to chemotherapeutic agents. Current research efforts are focused on the search for targets for the development of more effective and less toxic anti-leukemic drugs. CD47 has been suggested to be involved in chemo resistance and cell metastasis. Although several potential mechanisms were suggested to explain the therapeutic effect of CD47-targeting; the different effects by CD47 are still not well understood. In this study, we assessed the effect of doxorubicin on CD47 expression in jurkat T cells. Jurkat cells in complete medium were cultured with doxorubicin (50-1000nM) or control for 0, 24, 48 and 72 hours. Cells were stained with anti-CD47 FITC. Flow cytometry analysis was used for measurement of fluorescence intensity. Cell viability was detected using trypan blue exclusion test. Treatment with doxorubicin modulated the up-regulation of CD47 on membrane surfaces of jurkat cells with no significant killing of the cells. leukaemia cells exert their anti-apoptotic role through increased CD47 expression. CD47 is a novel functional protein in jurkat T cells with promising therapeutic potential and may provide insight for targeted therapy against T-ALL disease.

Cite

CITATION STYLE

APA

Uchendu, I. K., Orji, O. C., Agu, C. E., Chekwube, B. E., & Nwosu, T. F. (2018). CD47 is up-regulated on leukaemia cells to avoid apoptosis in vitro. Journal of Applied Pharmaceutical Science, 8(3), 99–103. https://doi.org/10.7324/JAPS.2018.8314

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free